Skip to content

Evidence Hub

Publication
Mar 24, 2024

An evaluation of the replicability of analyses using synthetic health data

This paper published in Scientific Reports describes a study evaluating the replicability ...
Start Reading
Blog
Mar 21, 2024

FDA releases draft guidance on non-interventional studies for drug and biological products

The Food and Drug Administration (FDA) continues to advance its RWE Program, this time ...
Start Reading
Presentation
Dec 13, 2023

Ten Things I have Learned About Synthetic Data Generation

Khaled El Emam, SVP & GM, Replica Analytics
Start Reading
Blog
Dec 7, 2023

Aetion’s comments to FDA on recent draft guidance on the substantial evidence standard

This week, Aetion submitted a letter to FDA commenting on the Agency’s recent draft ...
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Session 2: Perspectives from Health Regulators

Title: High-Fidelity Synthetic Data Applications for Data Augmentation
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Session 5: Applications in Complex Healthcare Settings

Title: Generating Synthetic Data for the NHS
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Session 4: Applications of Synthetic Data in the Life Sciences Industry II

Title: Applications of Privacy Enhancing Technology to Data Sharing at a Global ...
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Session 3: Applications of Synthetic Data in the Life Sciences Industry I

Title: Applications of Synthetic Data in Supporting Data Products and Analytics for Real ...
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Welcome / Opening remarks

Speaker: Khaled El Emam GM and SVP, Replica Analytics; Professor, University of Ottawa
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Session 1: Regulating Privacy Risks from Synthetic Data

Title: Assessing the Privacy Risks of Synthetic Data and Other PETs
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Session 6: New Applications

Title: Assessing Utility and Building Industry Trust for Imaging Data in Healthcare
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Closing Remarks

Speaker: Dorothee Bartels Chief Digital Officer, Aetion
Start Reading
Blog
Nov 29, 2023

Research Spotlight: A Deep Dive into a Real-World Reproducibility Study

Both real-world data (RWD) and real-world evidence (RWE) studies continue to effectively ...
Start Reading
Blog
Nov 16, 2023

Partnering to enhance Japanese RWD at a global scale: A Q&A with JMDC

JMDC, a leading Japanese health big data firm, and Aetion® recently announced a ...
Start Reading
Blog
Nov 8, 2023

Research Spotlight: Navigating Treatment Effectiveness in Rare Oncology with External Control Cohorts

Real-world data (RWD) has proven to be a pivotal tool in understanding patient treatment ...
Start Reading
Publication
Nov 1, 2023

Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets

This paper published in the Journal of Clinical Oncology: Clinical Cancer Informatics ...
Start Reading
Blog
Oct 23, 2023

What I saw at DIA RWE 2023

I am just back from Baltimore, Maryland, where I had the joy of attending DIA’s ...
Start Reading
Blog
Oct 19, 2023

Advancing RWE in Oncology with Aetion’s CARE Initiative

In late 2022, Aetion announced the launch of the Aetion Coalition to Advance Real‐World ...
Start Reading
Blog
Sep 1, 2023

What I saw at ICPE 2023

I just had the pleasure and privilege of attending the 39th International Conference on ...
Start Reading
Blog
Aug 29, 2023

Leveraging the SURF screening tool to understand how to identify whether RWE of effectiveness may be acceptable for regulatory decision-making for a clinical development program

Ulka Campbell, Ph.D., is Aetion’s Head of Scientific Strategy. In this role, she uses her ...
Start Reading
Publication
Aug 1, 2023

Consolidated Reporting Guidelines for Prognostic and Diagnostic Machine Learning Modeling Studies: Development and Validation.

The reporting of machine learning (ML) prognostic and diagnostic modeling studies is ...
Start Reading
Presentation
Aug 1, 2023

Demystifying HIPAA: Techniques for De-identifying Complex Multi-modal Data

Patricia Thaine, Co-Founder & CEO, Private AI
Start Reading
Publication
Jul 13, 2023

A comparison of synthetic data generation and federated analysis for enabling international evaluations of cardiovascular health

Our recent article in Scientific Reports entitled, A comparison of synthetic data ...
Start Reading
Presentation
Jun 14, 2023

Reuse health data safely via tech-enabled re-identification risk management

Braley Crandall, VP Operations, Replica Analytics
Start Reading